miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
about
Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and reviewThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisTGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness.A MicroRNA/Ubiquitin Ligase Feedback Loop Regulates Slug-Mediated Invasion in Breast Cancer.Epigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells.miRNA involvement in angiogenesis in age-related macular degeneration.Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.MicroRNA-373 promotes migration and invasion in human esophageal squamous cell carcinoma by inhibiting TIMP3 expression.miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma.MicroRNA-93-5p may participate in the formation of morphine tolerance in bone cancer pain mouse model by targeting Smad5.Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma.MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition of LKB1/PTEN/CDKN1A.microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.MicroRNA-93 inhibits apoptosis and promotes proliferation, invasion and migration of renal cell carcinoma ACHN cells via the TGF-β/Smad signaling pathway by targeting RUNX3.MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.miR-93 promotes TGF-β-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells.ZNRF3 contributes to the growth of lung carcinoma via inhibiting Wnt/β-catenin pathway and is regulated by miR-93.Acute hypoxia induces upregulation of microRNA-210 expression in glioblastoma spheroids.A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells.Quality Evaluation of Human Bone Marrow Mesenchymal Stem Cells for Cartilage Repair.Micro ribonucleic acid-93 promotes proliferation and migration of esophageal squamous cell carcinoma by targeting disabled 2RUNX1 promote invasiveness in pancreatic ductal adenocarcinoma through regulating miR-93.A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients.17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression.miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.MiR-93-5p Promotes Cell Proliferation through Down-Regulating PPARGC1A in Hepatocellular Carcinoma Cells by Bioinformatics Analysis and Experimental Verification.Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma.Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR-410.The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network.Inherited pancreatic cancer.Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China.Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patientsmiR-93 Promotes the Growth and Invasion of Prostate Cancer by Upregulating Its Target Genes , , andQ58714416
P2860
Q26785539-2B7E7569-ACF9-45D5-A41E-920F378D58B7Q26800055-4085D4A5-72E5-421B-B5A0-EF78384AE947Q33592822-0BB5BF78-031E-4868-B162-571DFFACC5F4Q33676240-C5422911-C55E-4D2B-95A7-B97527A931C7Q33745551-8BAB0C73-BE3D-480C-A958-83B1E4EB7E8EQ33771364-6E970BE7-FD87-482D-A02E-49F98CF21EE5Q35388346-1E73D088-062E-4720-B5B6-11C70EE44013Q35652848-9D3F8A7F-2E57-44F6-88DB-B113253DB624Q35781570-F4116BF1-A324-49F2-ADF0-FF8E0F5638FDQ35914705-E8A4E4A6-905C-445A-ABB7-2C3CFBAB4E7CQ36062736-132B4C5D-FEEC-4BBD-9B1C-D8D7B8B53789Q36413124-97610CEA-F9A3-489F-9097-024411892823Q36466853-48303F55-0209-4D41-9C7F-051604E1E78CQ36595028-B55577B5-F132-4B50-92D9-ED158DCAD56CQ36736286-5301604C-EBF3-4D1F-8CEC-271C1674AB5AQ37588418-05099D27-93E6-4072-A7C6-46EA24AA9C8AQ37687592-62DC8114-0C37-4BAB-A474-8EB6237F0A86Q37738099-67D735BE-A49E-43DE-BA21-CBE8F502B2D2Q38300511-A67BA3BE-3E3F-4CA2-9445-2BD2CE64BD99Q38695006-F95F3F23-0031-4654-BFC6-6446C00AC93BQ38703092-92936964-508C-4749-8B4E-891433AEBFEBQ38818616-CDB9DDDD-8A55-46E1-A951-4FF75F889D59Q38831235-3A7A0762-C180-417F-A5EC-F6EA7DD1A373Q38920264-49538C09-9E48-4DC4-9EE9-DE2165B58468Q40528981-37FDE031-F9DA-4B5F-954F-160EAEE12E53Q41395495-2FE31B2C-D729-46FD-BCCB-4055F8ED0404Q42375420-B63DD031-1C49-4AC8-B665-F1D894F4268BQ47097926-31E33B2B-9E59-441E-A884-3C08EDFDAC47Q47136432-1A54CCDA-AF77-4CA2-AD6D-52F177B6B364Q47160447-885954D9-6E57-41D6-953D-B44E22F6D35BQ47298818-532B78C8-EC19-4247-B56E-2AB66281A538Q47716490-D3FFD30C-9C7E-4B4E-9307-3D47D502C12EQ48162943-0D3977E8-8D79-4B2A-A72C-B19D1FF603D5Q50025868-877CD479-A269-40FE-BDC4-55CA71B9D040Q50087312-E25391E1-8589-4115-8CF0-F1D35DDA2CBAQ50146622-CF59A80C-4C90-47E7-AE02-14AE58A6D6DAQ52577567-E08AED3E-8DBF-452E-8C37-57EF4018FB78Q57120202-8574328E-45E4-44A9-9D51-B3CF3D185514Q57192834-37D2D9B5-AF26-40D5-899B-48BBBB769867Q58714416-93169B9E-4468-47B4-A52E-CC460DF3D1B5
P2860
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
@ast
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
@en
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
@nl
type
label
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
@ast
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
@en
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
@nl
prefLabel
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
@ast
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
@en
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
@en
P2093
M Suraokar
P2860
P2888
P304
P356
10.1038/ONC.2013.381
P407
P577
2013-09-16T00:00:00Z
P5875
P6179
1006586670